Argenx to Buy Forte Biosciences for $2.2 Billion
The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday.
Connecting Global Economies
Flash News
How to watch the women’s Citi Open: Streaming options for the Round of 32
Maker of Chips Sought by Apple Soars to No. 1 in China Stock Market
Israel to allow international force into Gaza under Trump ceasefire plan
What to know about the wildfires spreading in Spain and France
How to watch the men’s Citi Open: Streaming options for the Round of 32
The former military chief aiming to unseat Netanyahu in Israel
Paul Thomas Anderson, Maya Rudolph Private World With 4 Kids
Xabi Alonso backs Morgan Rogers to make an ‘instant impact’ at Chelsea
Argenx to Buy Forte Biosciences for $2.2 Billion
How Sussex are helping plug cricket’s state-school talent drain
Monday, July 27, 2026